(Total Views: 47)
Posted On: 11/07/2019 3:30:43 PM
Post# of 74550

$ARFXF News Article - ProMIS Neurosciences outlines best-in-class approach to amyloid-beta-targeting drug candidates for Alzheimer's disease https://marketwirenews.com/news-releases/prom...08780.html


My Twitter: WhyteStocks